Valneva SE (NASDAQ:VALN) and Pfizer Inc (NYSE:PFE) released pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate, VLA15, when given as a booster.
Lyme disease is a bacterial infection that can be spread to humans by infected ticks.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased